German biotech company eyes growing opportunities in Chinese market

STORY: German biotech company eyes growing opportunities in Chinese market SHOOTING TIME: Oct. 17, 2023 DATELINE: Nov. 5, 2023 LENGTH: 00:01:10 LOCATION: SHANGHAI, China CATEGORY: ECONOMY SHOTLIST: 1. various of Boehringer Ingelheim in an expo 2. SOUNDBITE (English): PAVOL DOBROCKY, President and CEO of Boehringer Ingelheim Greater China STORYLINE: It's the fifth time for German biotech company Boehringer Ingelheim to participate in the China International Import Expo (CIIE), which is on its sixth edition starting Sunday in Shanghai. Pavol Dobrocky, President and CEO of Boehringer Ingelheim Greater China, said that the company is eyeing growing opportunities in the Chinese market, especially because of the country's favorable business environment. SOUNDBITE (English): PAVOL DOBROCKY, President and CEO of Boehringer Ingelheim Greater China "Thanks to the regulatory reform in China, where the drug evaluation and approval mechanisms have been aligned with the global approval and evaluation mechanisms, and

Hong Kong speeds up efforts to become int'l innovation, technology center

STORY: Hong Kong speeds up efforts to become int'l innovation, technology center DATELINE: Sept. 6, 2023 LENGTH: 00:03:06 LOCATION: HONG KONG, China CATEGORY: ECONOMY/TECHNOLOGY SHOTLIST: 1. various of Hong Kong 2. SOUNDBITE 1 (Chinese): JOHN LEE, HKSAR Chief Executive 3. various of Hong Kong 4. various of a lab 5. SOUNDBITE 2 (English): CHEN WENHAN, Business manager at Boehringer Ingelheim Hong Kong 6. various of exhibitions 7. various of a speech delivered by HKSAR Chief Executive John Lee 8. SOUNDBITE 3 (Chinese): PAUL CHAN, Financial secretary of HKSAR government 9. various of the Cyberport and rocket launching 10. SOUNDBITE 4 (Chinese): CHAN CHING-CHUEN, Hong Kong scientist 11. shot of an automobile test STORYLINE: Hong Kong is working at full speed to build itself into an international centre of innovation and technology in a bid to transform and upgrade its economy. China's State Council released the Development Plan for Shenzhen Park of Hetao Shenzhen-Hong Kong Science and Technology Innovation Co

Foreign companies in Shanghai operate normally despite COVID-19 resurgence

STORY: Foreign companies in Shanghai operate normally despite COVID-19 resurgence DATELINE: April 6, 2022 LENGTH: 00:00:00 LOCATION: SHANGHAI, China CATEGORY: ECONOMY/HEALTH SHOTLIST: 1. various of Shanghai 2. various of Boehringer Ingelheim in Shanghai 3. SOUNDBITE 1 (Chinese): WANG BIN, General manager of Boehringer Ingelheim (China) Biopharmaceutical Co. LTD. 4. various of Standard Chartered in Shanghai 5. SOUNDBITE 2 (Chinese): JERRY ZHANG, Executive Vice Chairman and Chief Executive Officer, Standard Chartered China STORYLINE: Foreign companies in China's economic hub Shanghai said they operated normally and gave full support to the city's closed-off management amid the latest COVID-19 resurgence. Shanghai is an important manufacturing base of biological drugs. At a factory of German biotech company Boehringer Ingelheim in Shanghai, over 100 employees have been living at the plant for three weeks. A company executive highlighted the importance of maintaining normal production despite the pandemic,